Skip to main content

Advertisement

Log in

New Aspects of the Neurobiology of Migraine: The Role of the Hypothalamo-Pineal System

Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. A. M. Vein, Lectures in the Neurology of the Nonspecific Systems of the Brain [in Russian], Moscow (1974).

  2. G. N. Kryzhanovskii (ed.), Dysregulatory Pathology [in Russian], Meditsina, Moscow (2002).

    Google Scholar 

  3. F. I. Komarov, S. I. Rapoport, N. K. Malinovskaya, and V. N. Anisimov, Melatonin in Health and Disease [in Russian], Moscow (2004).

  4. Ya. I. Levin, Sleep and Pain [in Russian], Meditsina dlya Vsekh, No. 4, 27–28 (1998).

  5. Ya. I. Levin, G. R. Tabeeva, and I. G. Khanunov, “Effects of melatonin on the structure of sleep and clinical signs in patients with fibromyalgia,” in: Current Questions in Somnology [in Russian], Moscow (1998).

  6. V. V. Osipova and Ya. I. Levin, “Migraine in the ‘sleep-waking’ cycle,” Zh. Nevrol. Psikhiat., 106, No. 5, 9–15 (2006).

    CAS  Google Scholar 

  7. A. V. Sergeev, G. R. Tabeeva, and Yu. E. Azimova, “Central neuronal hyperexcitability – predisposition to migraine,” Ros. Zh. Boli, 27, No. 2, 3–12 (2010).

    Google Scholar 

  8. G. R. Tabeeva, “The chronobiology of migraine,” Zh. Nevrol. Psikhiat., 110, No. 4, Part 1, 104–112 (2010).

    CAS  Google Scholar 

  9. G. R. Tabeeva, and N. N. Yakhno, Migraine [in Russian], GEOTARMedia, Moscow (2011), pp. 327–408.

    Google Scholar 

  10. K. B. Alstadhaug, R. Salvesen, and S. Bekklund, “24-hour distribution of migraine,” Headache, 48, 95–100 (2008).

    Article  PubMed  Google Scholar 

  11. K. B. Alstadhaug, and R. Salvesen, “Migraine – mechanisms and consequences for treatment,” Tidsskr. Nor. Laegeforen, 127, 3064–3068 (2007).

    PubMed  Google Scholar 

  12. K. B. Alstadhaug, “Periodicity of migraine,” in: Migraine Disorders Research Trends, L. B. Clarke (ed.), Nova Science, New York (2007), pp. 107–144.

    Google Scholar 

  13. Handbook of Clinical Neurology,M. J. Amionff, F. Boller, D. F. Swaab (eds.),Vol. 79, The Human Hypothalamus: Basic and Clinical Aspects, Part I, Elsevier, Amsterdam, London (2003).

  14. M. J. Amionff, F. Boller, and D. F. Swaab, “Pain and addiction,” in: Handbook of Clinical Neurology,M. J. Amionff, F. Boller, D. F. Swaab (eds.),Vol. 80, The Human Hypothalamus: Basic and Clinical Aspects, Part II, Elsevier, Amsterdam, London (2004).

    Google Scholar 

  15. Y. Avnon, M. Nitzan, E. Sprecher, et al., “Different patterns of parasympathetic activation in uni- and bilateral migraineurs,” Brain, 126, 1660–1670 (2003).

    Article  PubMed  Google Scholar 

  16. A. Bahra, S. Matharu, C. Buchel, et al., “Brainstem activation specific to migraine headache,” Lancet, 357, 1016–1017 (2001).

    Article  PubMed  CAS  Google Scholar 

  17. T. Bartsch, M. L. Levy, P. J. Knight, and P. J. Goadsby, “Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamus,” Pain, 117, 30–39 (2005).

    Article  PubMed  CAS  Google Scholar 

  18. L. Benjamin, M. J. Levy, M. P. Lasalandra, et al., “Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos study,” Neurobiol. Dis., 16, 500–505 (2004).

    Article  PubMed  CAS  Google Scholar 

  19. I. Bettahi, D. Pozo, C. Osuma, et al., “Melatonin reduces nitric oxide synthase activity in rat hypothalamus,” J. Pineal Res., 20, 205–210 (1996).

    Article  PubMed  CAS  Google Scholar 

  20. M. E. Bigal, R. B. Lipton, P. R. Holland, and P. J. Goadsby, “Obesity, migraine, and chronic migraine – possible mechanisms of interaction,” Neurology, 68, 1851–1861 (2007).

    Article  PubMed  Google Scholar 

  21. H. Bolay, U. Reuter, A. K. Dunn, et al., “Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model,” Nat. Med., 8, 136–142 (2002).

    Article  PubMed  CAS  Google Scholar 

  22. J. Brun, B. Claustrat, P. Saddier, and G. Chazot, “Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses,” Cephalgia, 15, 136–139 (1995).

    Article  CAS  Google Scholar 

  23. R. Burstein and M. Jakubowski, “A unitary hypothesis for multiple triggers of the pain and strain of migraine,” J. Comp. Neurol., 493, 9–14 (2005).

    Article  PubMed  Google Scholar 

  24. E. Carstens, “Hypothalamic inhibition of rat dorsal horn neuronal responses to noxious skin heating,” Pain, 25, 95–107 (1986).

    Article  PubMed  CAS  Google Scholar 

  25. O. Casez, Y. Dananchet, and G. Besson, “Migraine and somnambulism,” Neurology, 65, 1334–1336 (2005).

    Article  PubMed  Google Scholar 

  26. J. I. Chuang, N. Mohan, M. L. Reitz, and R. J. Reiter, “Effect of melatonin on NF-kappa-B DNA-binding activity in the rat spleen,” Cell Biol. Int., 20, 687–692 (1996).

    Article  PubMed  CAS  Google Scholar 

  27. B. Claustrat, J. Brun, M. Geoffriau, et al., “Nocturnal plasma melatonin profile and melatonin kinetics during infusion in status migrainosus,” Cephalgia, 17, 511–517 (1997).

    Article  CAS  Google Scholar 

  28. B. Claustrat, C. Loisy, J. Brun, et al., “Nocturnal plasma melatonin levels in migraine: a preliminary report,” Headache, 29, 242–245 (1989).

    Article  PubMed  CAS  Google Scholar 

  29. N. Dahmen, M. Kasten, S. Wieczorek, et al., “Increased frequency of migraine in narcoleptic patients: a confirmatory study,” Cephalgia, 23, 14–19 (2003).

    Article  CAS  Google Scholar 

  30. M. W. De Vries and F. P. Peeters, “Melatonin as a therapeutic agent in the treatment of sleep disturbances in depression,” J. Nerv. Ment. Dis., 185, 201–202 (1997).

    Article  Google Scholar 

  31. G. Della Marca, C. Vollono, M. Rubino, et al., “Dysfunction of arousal systems in sleep-related migraine without aura,” Cephalgia, 26, 857–864 (2006).

    Article  CAS  Google Scholar 

  32. M. Denuelle, N. Fabre, P. Payoux, et al., “Hypothalamic activation in spontaneous migraine attacks,” Headache, 47, 1418–1426 (2007).

    PubMed  Google Scholar 

  33. J. D. Dexter, “The relationship between stage III + IV + REM sleep and arousals with migraine,” Headache, 19, 364–369 (1979).

    Article  PubMed  CAS  Google Scholar 

  34. R. Dubbels, R. J. Reiter, E. Klenke, et al., “Melatonin in edible plants identified by radioimmunoassay and by high performance liquid chromatography-mass spectrometry,” J. Pineal Res., 18, 28–31 (1995).

    Article  PubMed  CAS  Google Scholar 

  35. M. Ebadi, P. Govitrapong, P. Phansuwan-Pujito, et al., “Pineal opioid receptors and analgesic action of melatonin,” J. Pineal Res., 24, 193–200 (1998).

    Article  PubMed  CAS  Google Scholar 

  36. M. T. Epstein, J. M. Hockaday, and T. D. Hockaday, “Migraine and reproductive hormones throughout the menstrual cycle,” Lancet, No. 1, 543–548 (1975).

  37. A. Espinar, A. Garcia-Oliva, E. M. Isorn, et al., “Neuroprotection by melatonin from glutamate-induced excitotoxicity during development of the cerebellum in the chick embryo,” J. Pineal Res., 28, 81–88 (2000).

    Article  PubMed  CAS  Google Scholar 

  38. F. Facchinetti, L. Sgarbi, and F. Piccinini, “Hypothalamic resetting at puberty and the sexual dimorphism of migraine,” Funct. Neurol., 15, Supplement 3, 137–142 (2000).

    PubMed  Google Scholar 

  39. J. C. Galego, J. P. Cupillo, J. A. Cordeiro, and W. A. Tognola, “Clinical features of episodic migraine and transformed migraine: a comparative study,” Arq. Neuropsiquiatr., 60, 912–916 (2002).

    Article  PubMed  Google Scholar 

  40. J. J. Garcia, R. J. Reiter, J. M. Guerrero, et al., “Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation,” FEBS Lett., 408, 297–300 (1997).

    Article  PubMed  CAS  Google Scholar 

  41. N. J. Giffin, L. Ruggiero, R. B. Lipton, et al., “Premonitory symptoms in migraine. An electronic diary study,” Neurology, 60, 935–940 (2003).

    Article  PubMed  CAS  Google Scholar 

  42. R. Goder, G. Fritzer, A. Kapsokalyvas, et al., “Polysomnographic findings in nights preceding a migraine attack,” Cephalgia, 21, 31–37 (2001).

    Article  CAS  Google Scholar 

  43. C. Godson and S. M. Reppert, “The Mel1a melatonin receptor is coupled to parallel signal transduction pathways,” Endocrinology, 138, 397–404 (1997).

    Article  PubMed  CAS  Google Scholar 

  44. S. Gori, N. Morelli, M. Maestri, et al., “Sleep quality, chronotypes and preferential timing of attacks in migraine without aura,” J. Headache Pain, 6, 258–260 (2005).

    Article  PubMed  Google Scholar 

  45. F. Granella, G. Sances, C. Zanferrari, et al., “Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women,” Headache, 33, 385–389 (1993).

    Article  PubMed  CAS  Google Scholar 

  46. B. Guldiken, S. Guldiken, M. Demier, et al., “Low leptin levels in migraine: a case controls study,” Headache, 48, 1103–1107 (2008).

    Article  PubMed  Google Scholar 

  47. S. R. Haut, M. E. Bigal, and R. B. Lipton, “Chronic disorders with episodic manifestations: focus on epilepsy and migraine,” Lancet Neurol., 5, 148–157 (2006).

    Article  PubMed  Google Scholar 

  48. S. P. Hunt, A. Pini, and G. Evan, “Introduction of c-fos-like protein in spinal cord neurons following sensory stimulation,” Nature, 328, 1686–1704 (1987).

    Article  Google Scholar 

  49. A. Kalsbek, I. F. Palm, S. E. La Fleur, et al., “SCN outputs and the hypothalamic balance of life,” J. Biol. Rhythms, 21, 458–469 (2006).

    Article  Google Scholar 

  50. S. Kutlu, M. Ozcan, S. Canpolat, et al., “Effect of ghrelin on pain threshold in mice,” Firat. Tip. Dergisi., 10, 898–91 (2005).

    Google Scholar 

  51. M. Lauritzen, “Pathophysiology of the migraine aura. The spreading depression theory,” Brain, 117, 199–210 (1994).

    Article  PubMed  Google Scholar 

  52. E. M. Lichten, J. B. Lichten, A. Whitty, and D. Pieper, “The confirmation of a biochemical marker for women’s hormonal migraine: the depo-estradiol challenge test,” Headache, 35, 367–371 (1996).

    Article  Google Scholar 

  53. J. Lu, S. Sherman, M. Devor, and C. B. Saper, “A putative flip-flop switch for control of REM sleep,” Nature, 441, 589–594 (2006).

    Article  PubMed  CAS  Google Scholar 

  54. I. Lund, Y. Ge, L. C. Yu, et al., “Repeated massage-like stimulation induces long-term effects on nociception – contribution of oxytocinergic mechanisms,” Eur. J. Neurosci., 16, 330–338 (2002).

    Article  PubMed  Google Scholar 

  55. A. Malick, M. Jakubowski, J. K. Elmquist, et al., “A neurohistochemical blueprint for pain-induced loss of appetite,” Proc. Natl. Acad. Sci. USA, 98, 9930–9935 (2001).

    Article  PubMed  CAS  Google Scholar 

  56. A. Malick, A. M. Strassman, and R. Burnstein, “Trigeminohypothalamic and reticulohypothalamic tract neurons in the upper cervical spinal cord and caudal medulla of the rat,” J. Neurophysiol., 84, 2078–2112 (2000).

    PubMed  CAS  Google Scholar 

  57. S. P. Markey, S. Higa, M. Shih, et al., “The correlation between human plasma melatonin levels and urinary 6-hydroxymelatonin excretion,” Clin. Chim. Acta, 150, 221–225 (1985).

    Article  PubMed  CAS  Google Scholar 

  58. J. L. Medina and S. Diamond, “Cyclical migraine,” Arch. Neurol., 38, 343–344 (1981).

    Article  PubMed  CAS  Google Scholar 

  59. A. Menendez-Pelaez, B. Poeggeler, R. J. Reiter, et al., “Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence,” J. Cell. Biochem., 53, 373–382 (1993).

    Article  PubMed  CAS  Google Scholar 

  60. F. P. Monnet, “Melatonin modulates [3H]serotonin release in the rat hippocampus: effects of circadian rhythm,” J. Neuroendocrinol., 14, 194–199 (2002).

    Article  PubMed  CAS  Google Scholar 

  61. G. Murialdo, S. Fonzi, P. Costelli, et al., “Urinary melatonin excretion throughout the ovarian cycle in menstrually regulated migraine,” Cephalgia, 14, 205–209 (1994).

    Article  CAS  Google Scholar 

  62. J. E. Nagtegaal, M. W. Laurant, G. A. Kerkhof, et al., “Effects of melatonin on the quality of life in patients with delayed sleep phase syndrome,” J. Psychosom. Res., 48, 45–50 (2000).

    Article  PubMed  CAS  Google Scholar 

  63. R. J. Orts and B. Benson, “Inhibition effects on serum and pituitary LH by a melatonin-free extract of bovine pineal glands,” Life Sci. II, 12, 513–519 (1973).

    Article  PubMed  CAS  Google Scholar 

  64. S. Overem, J. A. van Vliet, G. J. Lammers, et al., “The hypothalamus in episodic brain disorders,” Lancet Neurol., No. 1, 437–444 (2002).

  65. T. Paiva, A. Batista, P. Martins, and A. Martins, “The relationship between headaches and sleep disturbance,” Headache, 35, 590–596 (1995).

    Article  PubMed  CAS  Google Scholar 

  66. M. F. Peres, M. Sanchez del Rio, M. L. Seabra, et al., “Hypothalamic involvement in chronic migraine,” J. Neurol. Neurosurg. Psychiatry, 71, 747–751 (2001).

    Article  PubMed  CAS  Google Scholar 

  67. M. F. Peres, M. A. Stiles, H. C. Siow, et al., “Chronobiological features in episodic and chronic migraine,” Cephalgia, 23, 590–591 (2003).

    Google Scholar 

  68. M. F. Peres, E. Zukerman, F. da Cunha Tanuri, et al., “Melatonin, 3mg, is effective for migraine prevention,” Neurology, 63, 757 (2004).

    Article  PubMed  CAS  Google Scholar 

  69. M. F. P. Peres, “Melatonin, the pineal gland and their implication for headache disorders,” Cephalgia, 25, 403–411 (2005).

    Article  CAS  Google Scholar 

  70. S. J. Perotuka, “Migraine: a chronic sympathetic nervous system disorder,” Headache, 44, 53–64 (2004).

    Article  Google Scholar 

  71. S. J. Peroutka, “Dopamine and migraine,” Neurology, 49, 650–656 (1997).

    Article  PubMed  CAS  Google Scholar 

  72. C. J. M. Poole and S. L. Lightman, “Inhibition of vasopressin secretion during migraine,” J. Neurol. Neurosurg. Psychiatry, 51, 1441–1444 (1988).

    Article  PubMed  CAS  Google Scholar 

  73. N. M. Ramadan, “The link between glutamate and migraine,” CNS Spectr., 8, 446–449 (2003).

    PubMed  Google Scholar 

  74. R. J. Reiter, J. R. Calvo, M. Karbownik, et al., “Melatonin and its relation to the immune system and inflammation,” Ann. N.Y. Acad. Sci., 917, 376–386 (2000).

    Article  PubMed  CAS  Google Scholar 

  75. R. J. Reiter, “Pineal melatonin: cell biology of its synthesis and of its physiological interactions,” Endocr. Rev., 12, 151–180 (1991).

    Article  PubMed  CAS  Google Scholar 

  76. S. M. Reppert, C. Godson, C. D. Mohle, et al., “Molecular characterization of a second melatonin receptor expressed in human retina and grain: the Mel1b melatonin receptor,” Proc. Natl. Acad. Sci. USA, 92, 8734–8738 (1995).

    Article  PubMed  CAS  Google Scholar 

  77. G. Sances, F. Granella, R. E. Nappi, et al., “Course of migraine during pregnancy and postpartum: a prospective study,” Cephalgia, 23, 197–205 (2003).

    Article  CAS  Google Scholar 

  78. E. Savaskan, G. Olivieri, L. Brydon, et al., “Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer’s disease,” Neurosci. Lett., 308, 9–12 (2001).

    Article  PubMed  CAS  Google Scholar 

  79. A. Y. Shaikh, J. Xu, Y. Wu, et al., “Melatonin protects bovine cerebral endothelial cells from hyperoxia-induced DNA damage and death,” Neurosci. Lett., 229, 193–197 197

  80. S. D. Silberstein, A. H. Elkind, C. Schreiber, and C. Keywood, “A randomized trial of frovatriptan for intermittent prevention of menstrual migraine,” Neurology, 63, 261–269 (2004).

    Article  PubMed  CAS  Google Scholar 

  81. S. D. Silberstein, “The role of sex hormones in headache,” Neurology, 42, No. 3, Suppl. 2, 37–42 (1992).

    CAS  Google Scholar 

  82. W. F. Stewart, A. Shechter, and B. K. Rasmussen, “Migraine prevalence: a review of population-based trends,” Neurology, 44, Suppl. 4, 17–23 (1994).

    Google Scholar 

  83. F. Wang, J. C. Li, C. F. Wu, et al., “Hypnotic activity of melatonin: involvement of semicarbazide hydrochloride, blocker of synthetic enzyme for GABA,” Acta Pharmacol. Scand., 23, 860–864 (2002).

    CAS  Google Scholar 

  84. C. Weiler, A. May,V. Limmroth, et al., “Brain stem activation in spontaneous human migraine attacks,” Nat. Med., No. 1, 658–660 (1995).

  85. F. S. Wu, Y. C. Yang, and J. J. Tsai, “Melatonin potentiates the GABA(A) receptor-mediated current in cultured chick spinal cord neurons,” Neurosci. Lett., 260, 177–180 (1999).

    Article  PubMed  CAS  Google Scholar 

  86. W. B. Young, M. F. Pres, and T. D. Rozen, “Modular headache theory,” Cephalgia, 21, 842–849 (2001).

    Article  CAS  Google Scholar 

  87. L. Y. Zang, G. Cosma, H. Gardner, and V. Vallyathan, “Scavenging of reactive oxygen species by melatonin,” Biochem. Biophys. Acta 1425, 469–477 (1998).

    Article  PubMed  CAS  Google Scholar 

  88. Q. Z. Zhang, Y. S. Gong, and J. T. Zhang, “Antagonistic effects of melatonin on glutamate release and neurotoxicity in cerebral cortex,” Zhongguo Yao Li Xue Bao, 20, 829–834 (1999).

    PubMed  CAS  Google Scholar 

  89. N. Zisapel, “Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting,” Cell. Mol. Neurobiol., 21, 605–616 (2001).

    Article  PubMed  CAS  Google Scholar 

  90. N. Zurak, “Role of the suprachiasmatic nucleus in the pathogenesis of migraine attacks,” Cephalgia, 17, 723–728 (1997).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 111, No. 8, Iss. 1, pp. 79–85, August, 2011.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tabeeva, G.R., Sergeev, A.V. & Gromova, S.A. New Aspects of the Neurobiology of Migraine: The Role of the Hypothalamo-Pineal System. Neurosci Behav Physi 43, 93–99 (2013). https://doi.org/10.1007/s11055-012-9697-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-012-9697-5

Keywords

Navigation